A recent randomized placebo-controlled crossover trial from the University of Illinois Urbana-Champaign sought to evaluate the effects of soluble corn fiber on cognitive performance, gut microbiota composition and the substances those bacteria produce, with the aim of identifying changes in the gut environment affecting cognitive function.
The peer-reviewed study, published in The Journal of Nutrition and funded in part by Tate & Lyle, found that a daily dose of SCF improved focus, while also boosting gut bacteria in ways that may support brain function.
The study
Over a four-week period, 42 healthy adults aged 45–75 consumed a daily dose of 18 g of Tate & Lyle’s PROMITOR Soluble Fibre or maltodextrin. Researchers assessed memory and attentional inhibition, a component of executive function, using a series of cognitive tests including the Flanker task. Attentional inhibition helps people filter out distractions and focus on relevant information when managing competing demands.
Findings
Compared with the control, SCF consumption improved response times on attentional inhibition tests and increased the abundance of Parabacteroides, a bacterial genus associated in previous research with anti-inflammatory effects, gut barrier function and the production of metabolites that may play a role in gut-brain communication.
Conclusion
While SCF consumption improved attentional inhibition and increased the abundance of Parabacteroides, the researchers did not find evidence that microbiome changes directly mediated the cognitive effects. However, their analyses suggested that the cognitive response to SCF may depend in part on Parabacteroides abundance, indicating that certain benefits could be partly influenced by the gut microbiota.
Implications
The study involved a relatively small group of healthy adults and was not designed to determine whether changes in the gut microbiome directly caused the observed cognitive effects.
Dr. Clare Leonard, VP nutrition and health sciences at Tate & Lyle, explained that the findings point to improvements in attentional inhibition, a key aspect of executive function that allows individuals to concentrate on important information while filtering out distractions.
“What makes these findings meaningful is that the improvements were detected after only four weeks of dietary intervention, suggesting PROMITOR Soluble Fibre may influence underlying biological pathways relevant to how the brain operates day to day,” she said. “Still, these results represent an early step, and larger, longer-term trials would help further quantify real world impact.”
Dr. Leonard noted that the study was exploratory and designed to identify early signals of cognitive and microbiome effects. While encouraged by the consistency between the cognitive and microbiome findings, she said larger and more diverse studies are needed to confirm the results, clarify the underlying mechanisms and determine whether the benefits observed in laboratory testing translate to real-world cognitive performance.
Fiber’s expanding role in healthy aging
While many fiber studies have focused on digestive or metabolic health, this research suggests a specific prebiotic fiber may also have measurable effects on cognition in healthy adults.
“Research is increasingly revealing its [fiber’s] broader role in the gut–brain axis, inflammation modulation, metabolic resilience and mineral absorption—all of which are core to healthy aging,” Dr. Leonard told NI. “PROMITOR is particularly well placed—it delivers clinically validated digestive tolerance while selectively supporting the beneficial gut microbes that may influence systemic and cognitive pathways. As addressing healthy aging through diet becomes a mainstream consumer priority, fiber is transitioning from a ‘basic wellness’ ingredient to a foundational component of proactive, whole-body health—including cognitive vitality.”
Source: The Journal of Nutrition doi: 10.1016/j.tjnut.2026.101473 “Effects of Soluble Corn Fiber Consumption on Executive Functions and Gut Microbiota in Middle to Older Age Adults: A Randomized Controlled Crossover Trial.” Authors D. Alvarado, et al.
